| LDR | | | 00000cab a22000004 4500 |
| 001 | | | MAP20260006376 |
| 003 | | | MAP |
| 005 | | | 20260310165154.0 |
| 008 | | | 260226e20240808usa|| p |0|||b|eng d |
| 040 | | | $aMAP$bspa$dMAP |
| 084 | | | $a931.1 |
| 245 | 1 | 0 | $aLongevity biotechnology$b: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity$cYu-Xuan Lyu...[et al.] |
| 520 | | | $aThis article presents a comprehensive review of recent advances in longevity biotechnology, integrating artificial intelligence, biomarkers, geroscience, and clinical applications. It describes progress in biomarker identification, biological clock development, and AI-driven drug discovery. It also addresses the mechanisms of ageing, therapeutic interventions, and the role of prevention-oriented longevity medicine. The text highlights the need for multidisciplinary approaches to extend healthy life and improve future healthcare |
| 540 | | | $aLa copia digital se distribuye bajo licencia "Attribution 4.0 International (CC BY 4.0)"$fCC BY 4.0$uhttps://creativecommons.org/licenses/by/4.0$943 |
| 650 | | 4 | $0MAPA20080564872$aBiotecnología |
| 650 | | 4 | $0MAPA20080555016$aLongevidad |
| 650 | | 4 | $0MAPA20080562649$aGerontología |
| 650 | | 4 | $0MAPA20080611200$aInteligencia artificial |
| 650 | | 4 | $0MAPA20080564353$aTercera edad |
| 650 | | 4 | $0MAPA20080568771$aEnvejecimiento |
| 700 | 1 | | $0MAPA20260003757$aYu-Xuan, Lyu |
| 710 | 2 | | $0MAPA20260004327$aAging-US |
| 773 | 0 | | $tAging Review$gVol. 16, No. 20 October 16, 2024 ; 22 p. |
| 856 | | | $uhttps://pubmed.ncbi.nlm.nih.gov/39418098/ |
